Collins, G. P., Clevenger, T. N., Burke, K. A., Yang, B., MacDonald, A., Cunningham, D., Fox, C. P., Goy, A., Gribben, J., Nowakowski, G. S., Roschewski, M., Vose, J. M., Vallurupalli, A., Cheung, J., Raymond, A., Nuttall, B., Stetson, D., Dougherty, B. A., Schalkwijk, S., Carnevalli, L. S., …Flinn, I. (2021). A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies. Leukemia & Lymphoma, 62(11), 2625-2636. https://doi.org/10.1080/10428194.2021.1938027